Saudi Arabia Contract Manufacturing Organizations Market Report 2022: Rising Pharmaceutical Investment Drives Growth – ResearchAndMarkets.com

0

DUBLIN–(BUSINESS WIRE)–The “Saudi Arabia Contract Manufacturing Organization Market, by Type (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing, Secondary Packaging), by End-User, by Region , Competition Forecast and Opportunities, 2027″ report has been added to from ResearchAndMarkets.com offer.

The contract manufacturing organization market in Saudi Arabia is expected to grow at a steady rate during the forecast period 2023-2027. The growth of the market is driven by rising investments in the development of the pharmaceutical industry and drug development processes.

The contract manufacturing organization market in Saudi Arabia is segmented on the basis of type, end-user, competitive landscape and regional distribution. Based on type, the market is fragmented into active pharmaceutical ingredient (API) manufacturing, finished dosage formulation (FDF) development and manufacturing, and secondary packaging.

The active pharmaceutical manufacturing (API) segment is expected to capture the highest market share during the forecast period. Rising demand for Pharmaceutical Ingredients (APIs) in the design and manufacturing of pharmaceuticals to increase drug efficacy is driving the growth of the segment.

Key target audience:

  • Market research and consulting firms

  • Government bodies such as regulators and policy makers

  • Organizations, forums and alliances

The study is helpful in providing answers to several critical questions that are important for industry stakeholders such as service providers, end users, etc., besides enabling them to form marketing strategies. investment and capitalize on market opportunities.

Report Scope:

In this report, the Saudi Arabia Contract Manufacturing Organization Market has been segmented into the following categories, in addition to industry trends which have also been detailed below:

Saudi Arabia Contract Manufacturing Organization Market, By Type:

  • Manufacturing of Active Pharmaceutical Ingredients (API)

  • Development and manufacturing of finished dosage formulations (FDF)

  • Secondary packaging

Saudi Arabia Contract Manufacturing Organization Market, By End User:

  • Major Pharmaceuticals

  • Small and medium-sized pharmaceutical products

  • Generic pharmaceutical companies

  • Others

Saudi Arabia Contract Manufacturing Organization Market, By Region:

  • western region

  • Eastern region

  • North & Center Region

  • Southern Region

Main topics covered:

1. Product introduction

2. Research methodology

3. Impact of COVID-19 on the Saudi Arabia Contract Manufacturing Organization Market

4. Voice of the customer

5. Executive summary

6. Saudi Arabia Contract Manufacturing Organization Market Outlook

6.1. Market size and forecast

6.1.1. By value

6.2. Market share and forecasts

6.2.1. By Type (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing, Secondary Packaging)

6.2.2. By end user (large pharma, small and medium sized pharma, generic pharma, others)

6.2.3. By company (2021)

6.2.4. By region

6.3. Commodity Market Map

7. Saudi Arabia Active Pharmaceutical Ingredients (API) Manufacturing Organizations Market Outlook

7.1. Market size and forecast

7.1.1. By value

7.2. Market share and forecasts

7.2.1. Per end user

8. Saudi Arabia Finished Dosage Formulation (FDF) Development and Manufacturing Organization Market Outlook

8.1. Market size and forecast

8.1.1. By value

8.2. Market share and forecasts

8.2.1. Per end user

9. Saudi Arabia Finished Secondary Packaging Manufacturing Organizations Market Outlook

9.1. Market size and forecast

9.1.1. By value

9.2. Market share and forecasts

9.2.1. Per end user

10. Market Dynamics

10.1. Drivers

10.2. Challenges

11. Market trends and developments

12. Policy and regulatory landscape

13. Saudi Arabia Economic Profile

14. Competitive landscape

15. Strategic Recommendations

Companies cited

  • Saudi-Japanese Pharmaceutical Company (SAJAPHCO)

  • AJA Pharmaceutical Industries Company LTD

  • Saudi Pharmaceutical and Medical Device Industries Corporation (SPIMACO)

  • Jamjoom Pharmaceuticals Co.

  • Banjara Holdings

  • Pharmaceutical Batterjee

For more information about this report visit https://www.researchandmarkets.com/r/np8dgq

Share.

Comments are closed.